Notice Number: NOT-DA-06-033
Key Dates
Release Date: October 2, 2006
Issued by
National Institute on Drug Abuse (NIDA), (http://www.nida.nih.gov)
Addiction to, or dependence on, drugs of abuse is a major public health and economic problem. Genetic and genomic studies have identified genes and gene variants that potentially modulate the fundamental biological mechanisms underpinning addictive processes. Discovery of these genes/variants, while extremely valuable, is only a first step in understanding molecular mechanisms of addiction. The National Institute on Drug Abuse (NIDA) intends to publish a Program Announcement (PA) in the fall of 2006 encouraging basic functional genomic research in two areas: 1. functional validation to determine which candidate genes/variants have an authentic role in addictive processes, and 2. detailed elucidation of the molecular pathways and processes modulated by candidate genes/variants, particularly for those genes with an unanticipated role in addiction.
Inquiry
For further information regarding this potential PA, please contact:
John Satterlee, Ph.D.
Program Director, National Institute on Drug Abuse
Genetics and Molecular Neurobiology Research Branch
Division of Basic Neuroscience and Behavioral Research
6001 Executive Boulevard
Bethesda, MD 20892-9555
Phone: 301-435-1020
Email: satterleej@nida.nih.gov
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |